Literature DB >> 26329758

Tissue Inhibitors of Metalloproteinase-1 and 2 and Obesity Related Non-Alcoholic Fatty Liver Disease: Is There a Relationship.

Rokaya Abdelaziz1, Mohamed Elbasel, Serag Esmat, Kareem Essam, Sahar Abdelaaty.   

Abstract

BACKGROUND/AIMS: Non-alcoholic fatty liver disease is a spectrum of clinical conditions, including simple steatosis and non-alcoholic steatohepatitis (NASH). The aim of the study is to evaluate the tissue inhibitors of metalloproteinase-1 and 2 (TIMPs) as noninvasive predictors of NASH.
METHODS: Three groups were included in the study. Obese patients (n = 30) with normal liver enzymes were included in group I and obese patients (n = 30) with elevated liver enzymes with liver biopsy-based diagnosis of NASH were included in group II. Age-matched subjects (n = 30) formed the control as group III. The lipid profile, liver enzyme levels and levels of TIMPs were compared among all the patients and subjects.
RESULTS: Comparison of groups I and II showed significantly elevated levels of TIMP-1 and TIMP-2 in group II as compared to group I (p < 0.05). Similarly, comparison between groups II and III showed significantly increased levels of TIMP-1 and TIMP-2 in group II as compared to group III (p < 0.05). TIMP-1 (sensitivity 96.7%, specificity 100%) and TIMP-2 (sensitivity 93.3%, specificity 100%) showed high accuracy in NASH diagnosis.
CONCLUSION: TIMP-1 and TIMP-2 may be considered noninvasive markers for the diagnosis of NASH.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26329758     DOI: 10.1159/000439083

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  12 in total

1.  Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design.

Authors:  Bryan Rudolph; Nicole Bjorklund; Nadia Ovchinsky; Debora Kogan-Liberman; Adriana Perez; Mark Liszewski; Terry L Levin; Michelle Ewart; Qiang Liu; Xiaonan Xue; Shankar Viswanathan; Howard D Strickler
Journal:  Contemp Clin Trials       Date:  2018-10-27       Impact factor: 2.226

2.  MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis.

Authors:  Giuseppina Palladini; Laura Giuseppina Di Pasqua; Marta Cagna; Anna Cleta Croce; Stefano Perlini; Barbara Mannucci; Antonella Profumo; Andrea Ferrigno; Mariapia Vairetti
Journal:  Int J Mol Sci       Date:  2022-06-19       Impact factor: 6.208

Review 3.  Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis.

Authors:  Monica A Tincopa
Journal:  Endocrinol Diabetes Metab       Date:  2020-08-28

Review 4.  Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH).

Authors:  Hannah K Drescher; Sabine Weiskirchen; Ralf Weiskirchen
Journal:  Cells       Date:  2019-08-07       Impact factor: 6.600

5.  Differential effects of olive oil, soybean oil, corn oil and lard oil on carbon tetrachloride-induced liver fibrosis in mice.

Authors:  Yanan Gao; Xuguang Li; Qiang Gao; Li Fan; Haobin Jin; Yueping Guo
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

Review 6.  Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD.

Authors:  Viera Kupčová; Michaela Fedelešová; Jozef Bulas; Petra Kozmonová; Ladislav Turecký
Journal:  Int J Environ Res Public Health       Date:  2019-09-24       Impact factor: 3.390

7.  The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model.

Authors:  Philipp Schwabl; Eva Hambruch; Grant R Budas; Paul Supper; Michael Burnet; John T Liles; Manfred Birkel; Ksenia Brusilovskaya; Philipp Königshofer; Markus Peck-Radosavljevic; William J Watkins; Michael Trauner; David G Breckenridge; Claus Kremoser; Thomas Reiberger
Journal:  Biomedicines       Date:  2021-01-09

8.  Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague-Dawley rats.

Authors:  Victoria Svop Jensen; Henning Hvid; Jesper Damgaard; Helle Nygaard; Camilla Ingvorsen; Erik Max Wulff; Jens Lykkesfeldt; Christian Fledelius
Journal:  Diabetol Metab Syndr       Date:  2018-01-24       Impact factor: 3.320

9.  Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy.

Authors:  Obiageli Offor; Netanya Utay; David Reynoso; Anoma Somasunderam; Judith Currier; Jordan Lake
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

Review 10.  Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases.

Authors:  Francisco Javier Ruiz-Ojeda; Andrea Méndez-Gutiérrez; Concepción María Aguilera; Julio Plaza-Díaz
Journal:  Int J Mol Sci       Date:  2019-10-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.